Tirzepatide15 min readUpdated 2026-04-03

    Tirzepatide Weight Loss by Week: Monthly Timeline

    What to expect week by week and month by month on tirzepatide. Real data from clinical trials showing average weight loss at each stage of treatment.

    Medical Disclaimer

    This article is for educational purposes only. Individual results vary significantly based on starting weight, adherence to nutrition and exercise, dose, and individual metabolic factors. The data below represents clinical trial averages, not guaranteed outcomes.

    Month-by-Month Timeline

    Month 1 (Weeks 1-4): Starting Dose 2.5mg

    Average weight loss: 3-7 lbs (1-2.5% body weight)

    The 2.5mg dose is a titration dose designed to help your body adjust. You will notice reduced appetite within the first few days. Side effects like nausea are most common during this period. Focus on hydration and establishing healthy eating patterns rather than the scale.

    Month 2 (Weeks 5-8): Increase to 5mg

    Cumulative weight loss: 8-15 lbs (3-5% body weight)

    The 5mg dose is the first therapeutic dose for weight loss. Appetite suppression becomes more pronounced. Weight loss accelerates. Side effects may briefly return with the dose increase but typically resolve within 1-2 weeks.

    Month 3 (Weeks 9-12): 5mg or Increase to 7.5mg

    Cumulative weight loss: 12-22 lbs (5-8% body weight)

    Depending on response, your provider may keep you at 5mg or increase to 7.5mg. Weight loss continues at a steady pace. You may start noticing visible changes in how clothes fit. Energy often improves as the body adapts.

    Months 4-6 (Weeks 13-24): 7.5mg-10mg

    Cumulative weight loss: 20-40 lbs (8-15% body weight)

    This is typically the peak weight loss velocity phase. Most patients are at 7.5-10mg. Weight loss of 4-8 pounds per month is common. Blood pressure, blood sugar, and cholesterol often show significant improvements. Friends and family begin noticing changes.

    Months 7-9 (Weeks 25-36): 10mg-15mg

    Cumulative weight loss: 30-50 lbs (12-20% body weight)

    Weight loss continues but may slow slightly. Some patients reach their target dose; others may increase to 15mg. Short plateaus are common and normal. Non-scale victories (energy, mood, lab values, clothing sizes) become increasingly prominent.

    Months 10-12 (Weeks 37-52): Maintenance Dose

    Cumulative weight loss: 35-60+ lbs (15-22% body weight)

    Weight loss continues to slow as you approach equilibrium. Many patients lose an additional 5-10 pounds during this phase. Focus shifts from active weight loss to weight maintenance, lifestyle sustainability, and consolidating health gains.

    Factors That Affect Your Timeline

    Starting weight

    People with higher starting weights typically lose more total pounds but a similar percentage of body weight. A 300-pound person may lose 60+ pounds while a 200-pound person may lose 40 pounds, both representing approximately 20%.

    Diet and exercise

    Patients who maintain high protein intake and engage in regular resistance training consistently outperform the clinical trial averages. Lifestyle factors amplify the medication's effects.

    Dose achieved

    Higher doses produce greater weight loss on average. The 15mg dose produced 22.5% weight loss vs. 15% at 5mg in the SURMOUNT-1 trial. However, not everyone needs or tolerates the maximum dose.

    Individual metabolism

    Genetic factors, thyroid function, hormonal status, medications, sleep quality, and stress all influence individual response. Comparing your results to others is less useful than tracking your own consistent progress.

    Frequently Asked Questions

    How much weight can I lose in the first month on tirzepatide?

    During the first month at the starting dose of 2.5mg, most patients lose 3-7 pounds. This initial phase is primarily about adjusting to the medication, and the 2.5mg dose is intentionally subtherapeutic for weight loss. Do not be discouraged by modest early results. Significant weight loss accelerates as doses increase.

    When does tirzepatide weight loss peak?

    Weight loss velocity typically peaks between months 3-8, during the dose-escalation phase (5mg-15mg). Patients at 10-15mg doses often lose 4-8 pounds per month during this peak period. Weight loss then gradually slows as you approach your body's new equilibrium weight.

    How much total weight can I lose on tirzepatide?

    Clinical trials showed average total body weight loss of 15% at 5mg, 19.5% at 10mg, and 22.5% at 15mg over 72 weeks. For a 250-pound person, this translates to 37-56 pounds. Individual results vary widely, with some patients losing significantly more and others less.

    Is it normal for weight loss to slow down after a few months?

    Yes, this is completely normal. Early weight loss includes water and glycogen, which comes off quickly. As you lose weight, your caloric needs decrease, and weight loss naturally slows. A rate of 1-2 pounds per week during active treatment is excellent. Plateaus lasting 2-4 weeks are also normal and expected.

    Start Your Tirzepatide Journey

    See what tirzepatide can do for you. Compounded tirzepatide from $125/month with ongoing provider support.

    Explore Treatment Options

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the published clinical evidence show for compounded tirzepatide?

    Peer-reviewed evidence: Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. (Source: SURMOUNT-1, NEJM 2022). Trimi offers compounded tirzepatide starting at $125/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. — SURMOUNT-1, NEJM 2022
    In a 40-week head-to-head trial of patients with type 2 diabetes, tirzepatide 15 mg produced approximately 11.2 kg of body-weight reduction vs 5.7 kg on semaglutide 1 mg. — SURPASS-2, NEJM 2021
    Tirzepatide reduced the apnea-hypopnea index by approximately 27 to 30 events/hour at 52 weeks in adults with obesity and moderate-to-severe obstructive sleep apnea, vs roughly 5 events/hour reduction on placebo. — SURMOUNT-OSA, NEJM 2024

    Key Takeaways

    • Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. (Source: SURMOUNT-1, NEJM 2022)
    • In a 40-week head-to-head trial of patients with type 2 diabetes, tirzepatide 15 mg produced approximately 11.2 kg of body-weight reduction vs 5.7 kg on semaglutide 1 mg. (Source: SURPASS-2, NEJM 2021)
    • Tirzepatide reduced the apnea-hypopnea index by approximately 27 to 30 events/hour at 52 weeks in adults with obesity and moderate-to-severe obstructive sleep apnea, vs roughly 5 events/hour reduction on placebo. (Source: SURMOUNT-OSA, NEJM 2024)
    • Tirzepatide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Zepbound and Mounjaro). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: November 26, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2206038
    2. Frías JP, Davies MJ, Rosenstock J, et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2107519
    3. Wadden TA, Chao AM, Machineni S, et al. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-023-02597-w
    4. Aronne LJ, Sattar N, Horn DB, et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2023.24945
    5. Malhotra A, Grunstein RR, Fietze I, et al. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2404881
    6. U.S. Food and Drug Administration (2024). Zepbound (tirzepatide) Prescribing Information. FDA.Read Study

    Was this article helpful?

    Keep Reading

    Buy compounded semaglutide online in Texas for $99/month. Learn about Texas telehealth laws, compounding pharmacy access, and how to start affordable GLP-1 weight loss treatment.

    Detailed comparison of retatrutide vs tirzepatide: 24.2% vs 22.5% weight loss, mechanism differences, side effects, cost projections, and whether to wait or start now.

    Essential preparation guide for tirzepatide. Learn eligibility, costs, side effects, timeline, and how to prepare for successful weight management.

    Clinician-reviewed guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares.

    Start your GLP-1 journey — from $99/mo

    Get Started